Patents by Inventor Michael Noldner

Michael Noldner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
    Patent number: 10357530
    Abstract: The present invention relates to a combination of valerian root extract and lavender oil treating of sleep disorders, as well as to a combination of preparation comprising valerian root extract and lavender oil.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: July 23, 2019
    Assignee: Dr. Willmar Schwabe GmbH & Co. KG
    Inventors: Wilfried Dimpfel, Michael Nöldner
  • COMBINATION OF VALERIAN ROOT EXTRACT AND LAVENDER OIL FOR USE IN THE TREATMENT OF SLEEP DISORDERS
    Publication number: 20170296612
    Abstract: The present invention relates to a combination of valerian root extract and lavender oil for treating of sleep disorders, as well as to a combination of preparation comprising valerian root extract and lavender oil.
    Type: Application
    Filed: June 10, 2015
    Publication date: October 19, 2017
    Inventors: Wilfried Dimpfel, Michael Nöldner
  • Use of extracts from species
    Patent number: 7611734
    Abstract: The use of extracts from Pelargonium species or plant parts thereof, particularly from P. sidoides and P. reniforme for the prophylaxis or treatment of disease-related behavioral changes, the chronic or post-viral asthenia syndrome and/or stress-induced chronic pathological conditions as well as pharmaceutical preparations containing these extracts are described.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: November 3, 2009
    Assignee: ISO Arzneiminel GmbH & Co. KG
    Inventors: Shyam Sunder Chatterjee, Egon Koch, Michael Nöldner
  • Use Of Lavender Oil For The Prophylaxis And Treatment Of Neurasthenia, Somatization Disorders And Other Stress-Associated Diseases
    Publication number: 20080124410
    Abstract: The present invention relates to the prophylactic and therapeutic use of lavender oil for the treatment of neurasthenia, somatization disorders and other stress-associated diseases as well as medicaments, dietetic food products, preparations and capsules containing lavender oil as oral administration forms.
    Type: Application
    Filed: October 5, 2005
    Publication date: May 29, 2008
    Inventors: Angelika Dienel, Michael Noldner
  • Use of plant parts of prickly pear (opuntia) and/or extracts therefrom for the treatment of depressions
    Publication number: 20070134355
    Abstract: The present invention relates to the use of Opuntias, plant parts thereof and/or extracts or other preparations produced therefrom for the treatment of episodes of depression and depressive diseases or other affective disorders, which can be influenced by antidepressive agents, such as anxiety or panic disorders, bipolar depressions, somatization disorders and the premenstrual syndrome, as well as preliminary stages of such diseases.
    Type: Application
    Filed: October 26, 2004
    Publication date: June 14, 2007
    Inventors: Michael Nöldner, Karl Schotz
  • Use of extracts from pelargonium species
    Publication number: 20070014877
    Abstract: The present invention relates to the use of extracts from Pelargonium species or plant parts thereof, particularly from P. sidoides and P. reniforme for the prophylaxis or treatment of disease-related behavioural changes, the chronic or post-viral asthenia syndrome and/or stress-induced chronic pathological conditions as well as pharmaceutical preparations containing these extracts.
    Type: Application
    Filed: October 26, 2004
    Publication date: January 18, 2007
    Applicant: ISO ARZNEIMITTEL GBMBH & CO. KG
    Inventors: Shyam Chatterjee, Egon Kach, Michael Noldner
  • Use of rutin and isoharmnetin for treating depressive states and depression and other emotion disorders
    Publication number: 20060198914
    Abstract: The present invention relates to the use of rutin and isorhamnetin for the treatment of episodes of depression and depressive diseases as well as in case of other affective disorders and preliminary stages thereof.
    Type: Application
    Filed: March 2, 2004
    Publication date: September 7, 2006
    Applicant: Bioplanta Arzneimittel GmbH
    Inventors: Shyam Chatterjee, Michael Nöldner, Karl Schötz
  • Use of hyperforin and hyperforin-containing extracts in the treatment of dementia diseases
    Patent number: 6322824
    Abstract: The invention relates to the use of hyperforin and hyperforin-containing extracts of Hypericum perforatum L. (St. John's wort) in the treatment and prophylaxis of dementia diseases, including Alzheimer's disease, as well as the use of hyperforin and hyperforin-containing extracts for the preparation of a medicament for the treatment and prophylaxis of such dementia diseases.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: November 27, 2001
    Assignee: Willmar Schwabe GmbH & Co.
    Inventors: Shyam Sunder Chatterjee, Clemens Erdelmeier, Michael Nöldner
  • Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety
    Patent number: 6022889
    Abstract: The invention suggests a novel medical use of pure bilobalide or Ginkgo biloba extract with an increased bilobalide content as an anxiolytic or antidepressant.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: February 8, 2000
    Assignee: William Schwabe GmbH & Co.
    Inventors: Michael Noldner, Shyam S. Chatterjee
  • Benzopyranones, a method for producing them and uses therefor
    Patent number: 5428038
    Abstract: Novel 2H-1-benzopyran-2-ones (coumarin derivatives) of the general formula (I) are provided: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, X and Y are defined as in the specification, and the addition compounds thereof with physiologically compatible acids, intermediates and methods for the preparation thereof. The coumarin compounds possess a neuroprotective and anti-allergic action.
    Type: Grant
    Filed: October 8, 1993
    Date of Patent: June 27, 1995
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventors: Shyam S. Chatterjee, Michael Noldner, Hermann Hauer, Egon Koch